Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Aqua Bio Technology ASA
ASA
Active
Org 886582412
Karenslyst Allé 10, 0278
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2004 · 22 years old
7 employees
www.aquabiotech.no
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Aqua Bio Technology ASA
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 2M (+100% vs 2020)
2M
+100%
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
EBITDA
NOK millions
0M
-17M
-35M
-52M
-70M
2020: -16M
-16M
2020
2021: -17M (-6% vs 2020)
-17M
-6%
2021
2022: -19M (-12% vs 2021)
-19M
-12%
2022
2023: -20M (-5% vs 2022)
-20M
-5%
2023
2024: -56M (-180% vs 2023)
-56M
-180%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 248
516
942
1 976
813
Staff expenses
−7 535
−8 369
−7 741
−6 779
−4 935
EBITDA
−56 083
−20 233
−18 646
−16 989
−15 992
Depreciation & amort.
−6 763
−2 030
−3 645
−1 358
−113
EBIT
−62 846
−22 263
−22 292
−18 347
−16 105
Net financials
−170 439
−14 787
−3 497
−1 256
1 152
Profit before tax
−233 286
−37 050
−25 789
−19 603
−14 953
Tax
−121
−161
−356
−0
−249
Net profit
−233 164
−36 889
−25 433
−19 603
−14 704
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
149 709
99 622
56 438
34 162
16 238
Equity
6 147
62 723
−5 327
18 216
8 321
Long-term debt
42 001
0
0
0
1 106
Short-term debt
85 502
36 046
21 998
12 280
3 326
Total debt
127 503
36 046
21 998
12 280
4 432
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
4,1 %
This company
38,2 %
Market median
This company
Market median
89% below market
2020
2024
Return on equity
<−999 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,01×
This company
1,12×
Market median
This company
Market median
99% below market
2020
2024
Debt / equity
23,36×
This company
0,62×
Market median
This company
Market median
>999% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Aqua Bio Technology ASA
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
